ischemia times and, ultimately, discard. For example, in kidney transplantation, high offer acceptance in a donation service area (DSA) was associated with higher kidney yield (kidneys transplanted from a donor), lower cold ischemia time, and higher odds of local organ placement. 7 Despite potentially important practical implications, organ offer data are limited in complex ways that may obscure the expected association between offer acceptance and waitlist mortality. Specifically, organ offer data can only evaluate offers for eventually accepted organs, and programs can screen offers out of match runs (ie, never receive an offer) from donors with certain clinical characteristics; for example, lung programs may not transplant lungs from donors who recently smoked. Programs that aggressively screen offers could achieve good apparent offer acceptance despite providing poor access to transplant. Conversely, programs that consider every offer may have low apparent offer acceptance but provide better access to transplant. This may attenuate the expected association of offer acceptance with waitlist mortality because offer acceptance may no longer reflect program-level variability in access to transplant. Thus, due to the difficult and potentially confounding nature of offer acceptance data, an empirical evaluation is necessary to establish the association between offer acceptance and waitlist mortality.
In heart and lung transplantation, organ offer acceptance practices are particularly important due to relatively high rates of waitlist mortality 8, 9 and low rates of organ yield compared with kidney and liver transplantation. 10 Thoracic transplantation differs from kidney transplantation in important ways that may modify the previously established association of organ offer acceptance with organ yield and local placement of transplanted organs. 7 First, hearts and lungs are more difficult to transport than kidneys. This could create a stronger dependence between the acceptance practices of programs in proximity to the donor and organ yield. Because low acceptance at nearby programs may be more difficult to overcome, the offer acceptance practices of nearby heart and lung programs could be more strongly associated with organ yield and local placement than kidney offer acceptance. Second, the relatively lower rate of organ yield and lower level of program competition within DSAs could motivate organ procurement organizations to avoid offering and/or recovering hearts or lungs that would be unacceptable to local programs. 11 Because offer acceptance data can only evaluate eventually accepted organs, 7 this could attenuate the association of heart and lung offer acceptance with organ yield and, especially, local placement of transplanted organs compared with kidney offer acceptance. To determine whether these limitations modify the expected relationships, we estimated the empirical associations of offer acceptance with waitlist mortality, organ yield, and local placement in heart and lung transplantation. 
| ME THODS

| Heart and lung offer acceptance models
The heart and lung offer acceptance models were estimated with offer data (called match runs for individual donors) for donors recovered between July 1, 2016, and June 30, 2017. Discrete-time survival models estimated the probability of acceptance separately for offers to pediatric and adult candidates from match runs that ended in acceptance, and were estimated with generalized linear models with a logit-link. The time-scale was the number of previous offers, and a semi-parametric baseline hazard function (ie, the effect of the number of previous offers) ensured a non-zero probability of acceptance for each offer. The heart offer acceptance model strati- 
| Estimation of program-and DSA-level offer acceptance ratios
Heart and lung offer acceptance ratios were estimated separately from the offer acceptance models to alleviate the computational burden. After the heart and lung offer acceptance models were estimated, separate generalized linear mixed models (GLMMs) with a logit link estimated the program-and DSA-level offer acceptance ratios with a corresponding random intercept term. 13 The GLMMs accounted for donor and candidate characteristics through an offset term equal to the linear predictors from the appropriate offer acceptance model. These program-and DSA-level offer acceptance ratios were used as predictors in the primary analyses. The incidence but not the rate of waitlist mortality depends on the rate of transplant. 16, 17 Because high offer acceptance should affect waitlist mortality through better access to transplant, we anticipated that high offer acceptance would be associated with lower incidence of waitlist mortality but have no association with the rate of waitlist mortality. To better evaluate this hypothesis, we estimated the association of offer acceptance with incidence and rate of deceased donor transplant.
For both heart and lung transplantation, sensitivity analyses considered the effect of program-level offer acceptance ratios on removal due to death and, separately, removal due to becoming too sick to undergo transplant.
| Data analysis
All analyses were completed in R v3.3.3. The logistic models and the corresponding splines for continuous variables were estimated with the "mgcv" package. The survival models were estimated with the "survival" package, and the "mstate" package estimated the appropriate weights for the Fine and Gray methodology. 
| RE SULTS
3.1 | Characteristics of heart and lung offers (Table 1) For both heart and lung transplantation, the acceptance rate was highest for the first offer (28% and 24%, respectively) and substantially lower for organs with >10 previous offers (3%). Later offers involved, on average, older candidates and older recipients. In lung transplantation, later offers involved lower donor PO 2 levels and higher proportions of donors with a smoking history. In contrast, donor ejection fraction for heart offers was relatively constant early and late in the match run. 
| Characteristics of heart and lung candidates (Table 2)
Lung candidates were more likely to be listed during the cohort, or after July 1, 2016, than heart candidates (67% and 51%, respectively).
Lung candidates included in the period prevalent cohort were most likely to have undergone transplant (55%) or to remain on the waiting list (32%) at the end of the cohort (June 30, 2017). In contrast, removal from the waiting list due to death or becoming too sick to undergo transplant (8%) or other reasons (4%) occurred less often. Heart candidates were less likely to undergo transplant and more likely to remain on the waiting list than lung candidates (37% and 47%, respectively).
| Association of heart and lung offer acceptance with organ yield and local placement (Figure 1)
For both heart and lung transplantation, DSA-level offer acceptance was associated with organ yield and local placement of donors recovered in the DSA. Higher offer acceptance was associated with higher odds of organ yield (odds ratios [ORs]: heart, 1.09 1.21 1.35 ; lung, 1.04 1.11 1.19 ) and local placement of organs recovered in the DSA (OR: heart, 1.47 1.69 1.93 ; lung, 1.01 1.12 1.24 ). For example, doubling the DSA-level offer acceptance ratio was associated with 21% and 11% higher donor yield of, respectively, hearts and lungs. In addition, the association of lung offer acceptance with local placement of transplanted lungs was relatively weak, especially in comparison with heart transplantation.
| Association of program-level heart offer acceptance with incidence and rate of transplant and waitlist mortality (Figure 2)
Heart offer acceptance was strongly associated with both incidence Values are n (%) or mean (standard deviation). Removed due to death or becoming too sick was the only comparison that was not statistically significant.
TA B L E 2 Summary statistics of candidates waiting for a heart or lung transplant and candidate status at the end of the cohort period (June 30, 2017)
The adjusted odds ratios for a doubling of the DSAlevel offer acceptance ratios for organ yield and local placement of organs recovered in the local DSA. The organ yield analysis included recovered donors, and the local placement analysis included transplanted organs. The heart and lung analyses adjusted for common donor factors: hepatitis C, hepatitis B, history of hypertension, diabetes status, insulin dependence, mechanism of death, Public Health Service increased infectious risk, sex, blood type, cause of death, circumstance of death, past or current cigarette use, past or current cocaine use, past or current use of other drugs, current alcohol use, history of cancer, cardiac arrest after brain death, history of myocardial infarction, protein in urine, recovery outside of the contiguous United States, pO 2 , pO 2 /fiO 2 , serum creatinine, body mass index, and age. The heart models also adjusted for ejection fraction, and the lung models for time between support withdrawal and cross-clamp for donation after circulatory death. DSA, donation service area 
| Association of program-level lung offer acceptance with incidence and rate of transplant and waitlist mortality (Figure 3)
Lung offer acceptance was strongly associated with incidence (HR:
1.52 1.58 1.64 ) and rate of waitlist removal due to undergoing transplant (HR: 1.52 1.57 1.63 ). Lung offer acceptance also had the anticipated association with incidence (HR: 0.67 0.75 0.83 ) but not rate of waitlist death or removal due to becoming too sick to undergo transplant (HR: 0.89 0.99 1.10 ).
For example, a doubling of the offer acceptance ratios between lung transplant programs was associated with an approximately 25% lower hazard for incidence of waitlist removal due to death or becoming too sick. Similar associations were observed when separately considering removal due to death (HRs: incidence, 0.62 0.72 0.84 ; rate, 0.80 0.93 1.09 ) and becoming too sick (HRs: incidence, 0.67 0.78 0.91 ; rate, 0.89 1.04 1.21 ).
| D ISCUSS I ON
Despite the limitations of organ offer data, we found that high heart and lung offer acceptance within a DSA was associated with higher organ yield and lower incidence but not rate of waitlist mortality.
The distinguishing difference between waitlist mortality incidence and rate is that the former depends on the transplant rate. 16, 17 Because high offer acceptance was strongly associated with a higher transplant rate, programs with high offer acceptance likely had lower incidence of waitlist mortality because they performed transplants before candidates died or became too sick to undergo transplant. However, offer acceptance was likely not associated with pretransplant care beyond the effect on access to transplant due to lack of an association with the waitlist mortality rate. Thus, reducing variability in heart and lung offer acceptance practices may reduce program-level variability in the incidence of waitlist mortality.
Measuring offer acceptance among heart and lung transplant programs provides opportunities for improving organ yield and reducing variability in waitlist mortality. In particular, the association with organ yield suggests that improving offer acceptance could increase the number of transplants. SRTR recently integrated heart and lung offer acceptance into the program-specific reports to help programs benchmark acceptance practices relative to other programs. SRTR also provides offer acceptance cumulative sum (CUSUM) charts that allow monitoring of more recent offer acceptance practices and may help programs identify periods with unexpectedly low offer acceptance. 18 As an alternative approach, information could be provided during the offer process to improve acceptance, for example, the probability of receiving a better offer within a month. 19 Further research should investigate the efficacy of different approaches for improving offer acceptance.
F I G U R E 2
The adjusted hazard ratios for a doubling of the program-level heart offer acceptance ratios for the incidence and rate of removal from the waiting list due to transplant, death, being too sick to undergo transplant, and a composite of death and being too sick to undergo transplant. The distinguishing difference between incidence and rate is that incidence depends on the rate of every removal reason, while rate is independent of the other removal reasons. The analyses adjusted for several candidate characteristics at listing: sex, blood type, life support, height, missing height, weight, age at listing, intraaortic balloon pump, drug-treated hypertension, cardiovascular disease, peripheral vascular disease, pulmonary artery diastolic pressure, missing pulmonary artery diastolic pressure, current or former smoking, prior cardiac surgery, listed after July 1, 2016, and time on the list on July 1, 2016 Approaches to reducing variability in offer acceptance have po- Although most key variables were included in offer acceptance models, we could not account for all variables. For example, calculated panel-reactive antibodies (CPRAs) could affect offer acceptance practices, as offer acceptance for highly sensitized candidates may be lower than expected due to offers from incompatible donors.
Lower offer acceptance would likely limit access to transplant and therefore be associated with a higher incidence of waitlist mortality.
Unfortunately, CPRA data are insufficiently collected in heart and lung transplantation, although the recent heart policy called for additional data collection for sensitized candidates. The role of CPRA in offer acceptance and waitlist mortality should be revisited after collection of sufficient relevant data.
We have shown that organ offer acceptance practices may serve as an important tool for reducing variability in access to heart and lung transplant and improving organ yield. Reducing variability in access to transplant is especially important due to the corresponding increase in the incidence of waitlist mortality that results from low offer acceptance.
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